Dr. Wang is a bioimaging scientist, biostatistician, and Founder & CEO of PEyeVision, working at the intersection of artificial intelligence, biostatistics, and ophthalmic imaging to advance translational research and precision diagnostics.
Supported by NIH funding (including an NIH T32) across the UPMC Vision and Aging Institutes, her research integrates in vivo ocular imaging, AI-driven microvascular reconstruction, and clinical data science.
Her contributions have been recognized with the Eye & Ear Foundation Wiegand Fellowship, the Pitt Biostatistics Achievement Award, the Public Health Futures Award, and the ARVO Travel Grant. She also serves as a Review Editor for Frontiers in Ophthalmology.
Dr. Wang is a bioimaging scientist, biostatistician, and Founder & CEO of PEyeVision, working at the intersection of artificial intelligence, biostatistics, and ophthalmic imaging to advance translational research and precision diagnostics.
Supported by NIH funding (including an NIH T32) across the UPMC Vision and Aging Institutes, her research integrates in vivo ocular imaging, AI-driven microvascular reconstruction, and clinical data science.
Her contributions have been recognized with the Eye & Ear Foundation Wiegand Fellowship, the Pitt Biostatistics Achievement Award, the Public Health Futures Award, and the ARVO Travel Grant. She also serves as a Review Editor for Frontiers in Ophthalmology.